secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001493152-21-027052
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera completes $18M IPO on Nasdaq; net proceeds $15.4M, board expanded with independent directors
--------------------------------------------------------------------------------

- IPO of 3.6M units at $5.00/unit (1 share + 1 warrant) closed Nov 2, 2021; gross proceeds $18M, net ~$15.4M.
- Underwriters exercised full over-allotment for additional 540,000 warrants; warrants have $5.00 exercise price, 5-year term.
- Common stock and warrants trade on Nasdaq Capital Market under symbols BFRI and BFRIW.
- Board changes: Erica Monaco resigned; John Borer, Beth Hoffman, and Loretta Wedge appointed; Hoffman and Wedge independent.
- New directors appointed to audit, nominating, and compensation committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-027052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer